Venlafaxine ER 75mg Capsules

Manufacturer AUROBINDO Active Ingredient Venlafaxine Extended-Release Capsules(ven la FAX een) Pronunciation ven la FAX een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It is used to treat panic attacks.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Sep 1997
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Venlafaxine ER is an antidepressant medication that works by affecting certain natural chemicals in the brain (serotonin and norepinephrine) that help regulate mood. It is used to treat depression, anxiety disorders, and panic disorder. The 'ER' means extended-release, so it releases the medicine slowly over time, allowing for once-daily dosing.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Take your medication with food to help your body absorb it properly.
Swallow the capsule whole - do not crush, chew, or dissolve it or its contents.
If you have trouble swallowing the capsule, you can sprinkle its contents onto a small amount of applesauce. However, do not chew the mixture. Swallow it immediately and follow with a glass of cool water.

It's essential to establish a routine when taking your medication. Take it at the same time every day, as directed by your doctor or healthcare provider. Continue taking your medication even if you start feeling well, unless your doctor instructs you to stop.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication:

Store it at room temperature in a dry place, away from the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. Check with your pharmacist for guidance on the best disposal methods, and consider participating in local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
πŸ’‘

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily with food, at approximately the same time each day.
  • Swallow the capsule whole; do not crush, chew, or open the capsule, as this will destroy the extended-release properties.
  • Avoid alcohol consumption, as it can increase side effects like drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it may cause dizziness or drowsiness.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms. Your doctor will guide you on how to slowly reduce the dose if needed.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking, especially St. John's Wort, triptans, or other antidepressants.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 75 mg extended-release capsule once daily
Dose Range: 37.5 - 225 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial: 37.5-75 mg ER once daily; may increase by 75 mg/day at intervals of β‰₯4 days, up to 225 mg/day. Max: 225 mg/day.
Generalized Anxiety Disorder (GAD): Initial: 37.5-75 mg ER once daily; may increase by 75 mg/day at intervals of β‰₯4 days, up to 225 mg/day. Max: 225 mg/day.
Social Anxiety Disorder (SAD): Initial: 75 mg ER once daily. Max: 75 mg/day.
Panic Disorder (PD): Initial: 37.5 mg ER once daily for 7 days, then increase to 75 mg ER once daily; may increase by 75 mg/day at intervals of β‰₯7 days, up to 225 mg/day. Max: 225 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for routine use; safety and efficacy not established for MDD in pediatric patients <18 years. Use generally not recommended due to increased risk of suicidality.
Adolescent: Not established for routine use; safety and efficacy not established for MDD in pediatric patients <18 years. Use generally not recommended due to increased risk of suicidality.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 30-60 mL/min: Reduce total daily dose by 25%.
Moderate: CrCl <30 mL/min: Reduce total daily dose by 50%.
Severe: CrCl <30 mL/min: Reduce total daily dose by 50%.
Dialysis: Hemodialysis: Reduce total daily dose by 50% and administer after dialysis session.

Hepatic Impairment:

Mild: Child-Pugh A: No dosage adjustment generally needed, but consider 25% reduction.
Moderate: Child-Pugh B: Reduce total daily dose by 50%.
Severe: Child-Pugh C: Reduce total daily dose by 50% or more; use with caution.

Pharmacology

πŸ”¬

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and a weak inhibitor of dopamine reuptake. The antidepressant and anxiolytic effects are believed to be related to the potentiation of neurotransmitter activity in the CNS.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45%
Tmax: Venlafaxine: 5.5 hours (ER); ODV: 9 hours (ER)
FoodEffect: Food delays Tmax by 2-3 hours but does not affect AUC or Cmax of venlafaxine or ODV.

Distribution:

Vd: Venlafaxine: 7.5 L/kg; ODV: 5.7 L/kg
ProteinBinding: Venlafaxine: Approximately 27%; ODV: Approximately 30%
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: Approximately 5 hours; ODV: Approximately 11 hours
Clearance: Venlafaxine: 1.3 Β± 0.6 L/h/kg; ODV: 0.4 Β± 0.2 L/h/kg
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: Venlafaxine: Approximately 5% in urine; ODV: Approximately 30% in urine
⏱️

Pharmacodynamics

OnsetOfAction: Typically 1-2 weeks for initial therapeutic effects; full effects may take 4-6 weeks.
PeakEffect: Not precisely defined, but steady-state plasma concentrations are achieved within 3 days for venlafaxine and 4 days for ODV.
DurationOfAction: 24 hours (due to extended-release formulation and half-life of active metabolite).

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond 24 years of age; there was a reduction in risk with antidepressants compared to placebo in adults β‰₯65 years of age. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine is not approved for use in pediatric patients.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Fainting or changes in eyesight
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sexual problems, such as:
+ Decreased interest in sex
+ Difficulty having an orgasm
+ Ejaculation problems
+ Trouble getting or maintaining an erection
Serotonin syndrome, a potentially life-threatening condition that may occur, especially when taking certain other medications. Symptoms include:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Fast or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Difficulty sleeping
Feeling nervous, anxious, or excitable
Weight loss
Dizziness, drowsiness, tiredness, or weakness
Shakiness
Headache
Excessive sweating
Constipation, diarrhea, stomach upset, vomiting, or decreased appetite
Gas
Dry mouth
Vivid or unusual dreams
* Yawning

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of an allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Symptoms of serotonin syndrome (e.g., agitation, hallucinations, confusion, fast heart rate, sweating, muscle stiffness, twitching, fever, nausea, vomiting, diarrhea)
  • New or worsening thoughts of self-harm or suicide, especially in young adults
  • Unusual changes in behavior or mood (e.g., severe agitation, panic attacks, extreme restlessness, impulsivity, mania)
  • New or worsening high blood pressure (e.g., severe headache, blurred vision, pounding in your neck or ears)
  • Eye pain, changes in vision, or swelling or redness in or around the eye (may indicate angle-closure glaucoma)
  • Unusual bleeding or bruising
  • Seizures
  • Symptoms of hyponatremia (low sodium) such as headache, confusion, slurred speech, severe weakness, vomiting, loss of coordination, feeling unsteady
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have high blood pressure, as this may be relevant to your treatment.
If you have narrow-angle glaucoma, a condition that affects the eyes.
If you are currently taking a weight loss drug, as this may interact with the medication.
If you are taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these can interact with the medication.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. This is crucial, as combining these medications can lead to very high blood pressure.

Please note that this is not an exhaustive list of all potential interactions. It is vital to inform your doctor and pharmacist about all your medications, including:

Prescription and over-the-counter (OTC) drugs
Natural products
Vitamins

Sharing this information will help your doctor and pharmacist assess potential interactions and ensure it is safe for you to take this medication with your other drugs and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and other activities that require alertness. If you need to stop taking this medication, do not do so abruptly without consulting your doctor, as this may increase your risk of side effects, which can be severe and long-lasting. Instead, follow your doctor's instructions for a gradual discontinuation.

Regular blood pressure checks are crucial while taking this medication, as it may cause high blood pressure. Your doctor will advise you on the frequency of these checks.

To minimize potential risks, avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness or slow your reactions.

This medication may increase your risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor, especially if you have any concerns.

If you have bipolar disorder, be aware that this medication may trigger manic episodes. Contact your doctor immediately if you experience any symptoms of a manic episode.

Some individuals may be at a higher risk of eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, seek medical attention promptly.

Low blood sodium levels (hyponatremia) can occur with this medication, and in severe cases, this can be fatal. Discuss this risk with your doctor and report any concerns.

High cholesterol has been associated with this medication. If you have questions or concerns, consult your doctor.

This medication may affect the results of certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

You may notice remnants of the medication in your stool, but this is a normal and harmless occurrence. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary, so discuss this with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to discuss the potential benefits and risks to you and your baby. Taking this medication in mid to late pregnancy may lead to health problems for both the mother (such as postpartum bleeding) and the newborn. If you are breastfeeding, your doctor will help you weigh the risks and benefits to your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Mild tremor
  • Nausea
  • Vomiting
  • Dizziness
  • Mydriasis (dilated pupils)
  • Tachycardia
  • Bradycardia
  • Hypotension
  • Convulsions
  • QT prolongation
  • Ventricular tachycardia
  • Coma
  • Death

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is generally supportive and symptomatic. Activated charcoal may be considered if ingested recently. Monitor cardiac rhythm and vital signs.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (concurrent use or within 14 days of discontinuing MAOI or venlafaxine due to risk of serotonin syndrome)
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) - increased risk of serotonin syndrome
  • Linezolid (MAOI activity)
  • Methylene blue (MAOI activity)
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, antipsychotics, tricyclic antidepressants) - theoretical risk of QT prolongation
  • Warfarin (increased INR and bleeding risk)
  • CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine) - increased venlafaxine exposure, decreased ODV exposure
🟑

Moderate Interactions

  • Alcohol (may increase CNS effects and impair motor skills)
  • Cimetidine (inhibits first-pass metabolism of venlafaxine, minor effect on AUC)
  • Haloperidol (increased haloperidol AUC)
  • Imipramine (increased desipramine AUC)
  • Metoprolol (increased metoprolol AUC)
  • Indinavir (decreased indinavir AUC)
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Blood Pressure (BP) and Heart Rate (HR)

Rationale: Venlafaxine can cause dose-related increases in BP and HR.

Timing: Prior to initiation

Weight

Rationale: Changes in appetite and weight can occur.

Timing: Prior to initiation

Mental Status/Suicidal Ideation

Rationale: Assess baseline mood, anxiety, and risk of suicidality, especially in young adults.

Timing: Prior to initiation

Sodium levels (Na+)

Rationale: Risk of hyponatremia, especially in elderly or those on diuretics.

Timing: Consider in at-risk patients prior to initiation

πŸ“Š

Routine Monitoring

Blood Pressure (BP) and Heart Rate (HR)

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Maintain within normal limits or patient's baseline.

Action Threshold: Sustained clinically significant increases (e.g., >10-15 mmHg diastolic, >20 mmHg systolic) may warrant dose reduction or discontinuation.

Mental Status/Suicidal Ideation

Frequency: Weekly for the first 4 weeks, then every 2-4 weeks for the next 8 weeks, then periodically or as clinically indicated.

Target: Improvement in target symptoms, absence of suicidal thoughts/behaviors.

Action Threshold: Worsening depression, emergence of suicidal ideation, or unusual changes in behavior require immediate reassessment and intervention.

Weight

Frequency: Periodically, especially during long-term treatment.

Target: Maintain stable weight.

Action Threshold: Significant weight gain or loss may require dietary counseling or medication adjustment.

Sodium levels (Na+)

Frequency: Periodically in at-risk patients (elderly, diuretic use, volume depletion).

Target: 135-145 mEq/L

Action Threshold: Hyponatremia (<135 mEq/L) requires investigation and management.

Symptoms of Serotonin Syndrome

Frequency: Ongoing, especially when initiating or increasing dose, or when co-administered with other serotonergic drugs.

Target: Absence of symptoms.

Action Threshold: Agitation, hallucinations, delirium, tachycardia, labile BP, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea require immediate medical attention.

πŸ‘οΈ

Symptom Monitoring

  • Worsening depression or anxiety
  • Emergence of suicidal thoughts or behaviors
  • Unusual changes in behavior (e.g., agitation, irritability, aggression, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Symptoms of serotonin syndrome (e.g., agitation, confusion, rapid heart rate, sweating, muscle rigidity, tremors, fever, nausea, vomiting, diarrhea)
  • Symptoms of withdrawal (e.g., dizziness, headache, nausea, insomnia, irritability, anxiety, paresthesias, electric shock sensations, tremor, sweating, fatigue) upon discontinuation or dose reduction
  • New or worsening hypertension
  • Pupil dilation (mydriasis) and associated visual disturbances or eye pain (risk of angle-closure glaucoma)
  • Abnormal bleeding or bruising

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Exposure during late pregnancy may lead to complications in the neonate requiring prolonged hospitalization, respiratory support, and tube feeding. These complications can arise immediately upon delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but some studies suggest a possible small increased risk of certain congenital malformations (e.g., cardiac defects) with first-trimester exposure to SNRIs/SSRIs, though data are inconsistent.
Second Trimester: Not specifically associated with unique risks beyond general antidepressant exposure.
Third Trimester: Increased risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (poor feeding, irritability, respiratory distress, tremor, hypotonia, constant crying) if exposed late in the third trimester.
🀱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for venlafaxine, and any potential adverse effects on the breastfed infant from venlafaxine or from the underlying maternal condition. Monitor infants for sedation, poor feeding, and poor weight gain.

Infant Risk: L3 (Moderately Safe) - Monitor infant for adverse effects. Some infants may experience irritability, sleep disturbances, or poor feeding. Consider alternative if infant is premature or has underlying health issues.
πŸ‘Ά

Pediatric Use

Not approved for use in pediatric patients. Antidepressants, including venlafaxine, increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (aged 18-24) compared to placebo. Close monitoring for clinical worsening, suicidality, and unusual changes in behavior is essential if use is considered off-label.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for hyponatremia and falls. Dosage adjustments may be necessary based on renal or hepatic impairment, which are more common in the elderly. Monitor for orthostatic hypotension.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Venlafaxine ER capsules should be swallowed whole with food; do not crush, chew, or open, as this will disrupt the extended-release mechanism and lead to rapid drug release.
  • Patients may notice 'ghost tablets' (empty capsule shells) in their stool, which is normal and indicates the medication has been absorbed.
  • Dose-related increases in blood pressure are a known side effect; monitor BP regularly, especially during dose titration.
  • Discontinuation syndrome (withdrawal symptoms) is common and can be severe, especially with abrupt cessation. Tapering the dose slowly over several weeks is crucial.
  • Venlafaxine is a potent SNRI; caution is advised when switching from other serotonergic agents or when co-administering with other drugs that affect serotonin or norepinephrine.
  • Consider the risk of angle-closure glaucoma; patients with a history of narrow-angle glaucoma should be monitored.
πŸ”„

Alternative Therapies

  • Other SNRIs (e.g., Duloxetine, Desvenlafaxine, Levomilnacipran)
  • SSRIs (e.g., Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram)
  • Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline)
  • Atypical Antidepressants (e.g., Bupropion, Mirtazapine, Trazodone)
  • Other anxiolytics (e.g., Buspirone, Benzodiazepines for short-term use)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $30-$100+ per 30 capsules (75mg ER)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic), Tier 3 or Non-Formulary (Brand)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its use. Please read this guide carefully and review it again whenever you receive a refill. If you have any questions or concerns about this medication, don't hesitate to consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.